Clinical review demonstrates improved outcomes in premature infants through early screening and evolving treatments, highlighting effective strategies to prevent childhood blindness.
Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder unique to premature infants. As premature births increase in many areas of the world, ROP has become a leading cause of childhood blindness. A better understanding of the pathogenesis of ROP, adherence to strict screening guidelines, and evolution of treatment options have reduced the number of sight-threatening complications from ROP.
No takes yet. Share an insight, caveat, or question.
Alice L Bashinsky (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: